Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment

NCT02581592 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: TD-4208

Sponsor

Mylan Inc.

Collaborators

[object Object]